Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | DGKA | P23743 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | PAM | P19021 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1401476 | 0.88 | TSHR (0.45) | TSHRLMNAALDH1A1CYP1A2NFKB1 | |
| SCHEMBL4316216 | 0.79 | MGAM (0.36) | TSHRLMNACYP1A2GAANFKB1 | |
| SCHEMBL712108 | 0.79 | — | — | |
| SCHEMBL8725920 | 0.79 | PHF8 (0.48) | TSHRLMNACYP1A2HDAC3HDAC1 | |
| SCHEMBL10525779 | 0.78 | CNR2 (0.66) | LMNARECQLCYP1A2CNR2 | |
| Hydrochloric Acid SCHEMBL2229616 | 0.77 | — | — | |
| SCHEMBL1111039 | 0.74 | — | — | |
| SCHEMBL3232536 | 0.74 | — | — | |
| SCHEMBL1071335 | 0.74 | TSHR (0.40) | TSHRLMNAALDH1A1DGKARECQL | |
| SCHEMBL28697127 | 0.74 | TSHR (0.40) | TSHRLMNAALDH1A1DGKACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114983982-B | Sustained-release type oral ulcer hydrogel ulcer patch | 浙江大学 | 2023-09-29 | — | — | CN | claimed |
| CN-114983982-A | Slow-release type dental ulcer hydrogel ulcer plaster | 浙江大学 | 2022-09-02 | — | — | CN | claimed |
| CN-108384428-B | Light-resistant antibacterial waterborne polyurethane coating and preparation method thereof | 唐山德生科技有限公司 | 2021-08-31 | — | — | CN | claimed |
| CN-108362891-B | Prednisone magnetic immuno-chemiluminescence detection kit and application thereof | 北京勤邦生物技术有限公司 | 2020-09-25 | — | — | CN | claimed |
| CN-111205726-A | Water-based acrylic acid water-resistant road marking paint and preparation method thereof | 王春林 | 2020-05-29 | — | — | CN | claimed |
| CN-109337200-A | The application of nucleating agent VOC in reducing PP composite material | 成都金发科技新材料有限公司 | 2019-02-15 | — | — | CN | claimed |
| CN-105524356-A | Polypropylene microporous membrane porosity conditioning agent, microporous membrane and preparation method thereof | UNIV HENAN NORMAL | 2016-04-27 | — | — | CN | claimed |
| US-12428517-B2 | Moisture curable polyurethane composition and laminate | TOKUYAMA CORPORATION (JP) | 2025-09-30 | — | — | US | disclosed |
| US-20250297145-A1 | SURFACE TOLERANT ADHESIVE | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC | 2025-09-25 | — | — | US | disclosed |
| US-20250257162-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4516823-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-4486841-A2 | SURFACE TOLERANT ADHESIVE | Huntsman Advanced Materials Americas LLC (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2024214739-A1 | ADHESIVE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND SPECTACLES | 株式会社トクヤマ | 2024-10-17 | — | — | WO | disclosed |
| WO-2003022291-A1 | DERIVATIVES OF PARTIALLY DESULPHATED GLYCOSAMINOGLYCANS AS HEPARANASE INHIBITORS, ENDOWED WITH ANTIANGIOGENIC ACTIVITY AND DEVOID OF ANTICOAGULATING EFFECT | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2003-03-20 | — | — | WO | disclosed |
| US-20030013682-A1 | Derivatives of partially desulphated glycosaminologycans endowed with antiangiogenic activity and devoid of anticogulating effect | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2003-01-16 | — | — | US | disclosed |
| EP-1268558-A1 | DERIVATIVES OF PARTIALLY DESULPHATED GLYCOSAMINOGLYCANS ENDOWED WITH ANTIANGIOGENIC ACTIVITY AND DEVOID OF ANTICOAGULATING EFFECT | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2003-01-02 | — | — | EP | disclosed |
| US-20020040742-A1 | Treatment method for making heat exchanger hydrophilic and heat exchanger treated to be hydrophilic | KEIHIN THERMAL TECHNOLOGY CORPORATION (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-1154042-A1 | Treatment method for making heat exchanger hydrophilic and heat exchanger treated to be hydrophilic | Nippon Paint Co., Ltd. (JP) | 2001-11-14 | — | — | EP | disclosed |
| WO-2001055221-A1 | DERIVATIVES OF PARTIALLY DESULPHATED GLYCOSAMINOGLYCANS ENDOWED WITH ANTIANGIOGENIC ACTIVITY AND DEVOID OF ANTICOAGULATING EFFECT | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2001-08-02 | — | — | WO | disclosed |
| US-4088665-A | Process for the partial carbodiimidization of organic isocyanates | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013682-A1 | Derivatives of partially desulphated glycosaminologycans endowed with antiangiogenic activity and devoid of anticogulating effect | HPSE, SERPINC1, CSGALNACT1 | TSHR 1225/4885LMNA 1857/4885ALDH1A1 850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.